SPEL
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SPEL, covering 2022-08-19 to 2022-08-19. Get the full timeline:
Most recent: Clinical Trial Update: SPEL as Introductive Treatment Following Immune-chemotherapy as Consolidated Therapy for R/R DLBCL With p53 and/or c-Myc Expression [Phase 1, Phase 2]